Top Markets
#1 Velas Velas +367.72%
#2 Gravity Gravity +48.70%
#3 Galxe Galxe +41.28%
#4 Infinity Ground Infinity Ground +30.80%
#5 Wiki Cat Wiki Cat +26.84%
#6 Audiera Audiera +26.57%
#7 Fetch.ai Fetch.ai +26.24%
#8 Derive Derive +24.86%
#9 Aria.AI Aria.AI +20.75%
#10 Babylon Babylon +18.83%
Coin of the day
Velas Velas
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Classement en actions #96
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Prix de l'action
$38.41
Capitalisation boursière
$170.67B
Changement (1 jour)
1.17%
Changement (1 an)
-49.92%
Pays
DK
Échange Novo Nordisk A/S (NVO)

Catégorie

Healthcare
Capitalisation boursière
Revenus
plus
Bénéfices
Historique des prix
Ratio P/E
Ratio P/S
Ratio P/B
Marge opérationnelle
EPS
Fractionnements d’actions
Dividendes
Rendement du dividende
Actions en circulation
Ratio P/B pour Novo Nordisk A/S (NVO)
Ratio P/B au February 2026 TTM : 7.11
Selon les derniers rapports financiers et le cours de l'action de Novo Nordisk A/S, le ratio cours/valeur comptable actuel (TTM) est 7.11. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Novo Nordisk A/S de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3842 -10.24%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.4551 -65.48%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.364 -38.64%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5504 -64.14%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 5.9034 -17.00%
NL